Abbott strikes deals with heart valve replacement companies
July 30, 2015 at 11:12 AM EDT
July 30 (Reuters) - Abbott Laboratories on Thursday said it would buy a small private company and has invested in another, with an option to buy, as it places bets on the future growth potential of minimally invasive systems to replace diseased heart valves.